A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The University of Miami Health System delivers leading-edge patient care by the region’s best doctors, powered by the groundbreaking research of the University of Miami Leonard M. Miller School of Medicine. As South Florida’s only university-based medical system, UHealth is a vital component of the community that is leading the next generation of health care.
Miami, Florida of Columbia Clinical Trial Location
University of Miami Hospital
1400 NW 12th Ave,
Miami, FL 33136